NDA Partners Chairman Carl Peck, MD, announced today that Dr. Philip Chaikin, a senior pharmaceutical industry executive with extensive drug development experience in development strategy, regulatory strategy, clinical pharmacology, and clinical study design, has joined the firm as an Expert Consultant. Throughout his accomplished 30 year career, Dr. Chaikin secured numerous global drug approvals and was involved in the development and launch of several blockbuster drugs.
(PRWeb June 17, 2020)
Read the full story at https://www.prweb.com/releases/senior_pharmaceutical_drug_development_executive_philip_chaikin_pharmd_md_fcp_joins_nda_partners_as_expert_consultant/prweb17195522.htm
For more information, please visit
https://www.prweb.com/releases/senior_ph[...]t_consultant/prweb17195522.htm